Vinutha Vijayadeva to Liver Cirrhosis
This is a "connection" page, showing publications Vinutha Vijayadeva has written about Liver Cirrhosis.
Connection Strength
0.595
-
Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection. Clin Gastroenterol Hepatol. 2016 07; 14(7):1044-1055.e3.
Score: 0.124
-
Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study. Am J Gastroenterol. 2015 Aug; 110(8):1169-77; quiz 1178.
Score: 0.120
-
APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS). J Viral Hepat. 2014 Dec; 21(12):917-20.
Score: 0.112
-
The validity of serum markers for fibrosis staging in chronic hepatitis B and C. J Viral Hepat. 2014 Dec; 21(12):930-7.
Score: 0.108
-
Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis. 2013 Jul; 57(2):240-6.
Score: 0.102
-
All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus. Clin Infect Dis. 2016 Feb 01; 62(3):289-297.
Score: 0.030